While high levels of PI epitope‐specific PB CD4+ T‐cell proliferation were evident in AB− and AB+ at‐risk FDR and within 3 months of T1D diagnosis relative to healthy controls carrying HLA risk alleles, they declined in individuals with T1D for longer than 3 months. The gene discussed is CD4; the disease is type 1 diabetes mellitus.